More Treatments for All People More Quickly
We conduct research and support activities that address long-standing challenges in translational research so that new treatments and other health solutions reach people faster.
Latest News
Read our latest research news or follow coverage of our translational science activities through national and local media.
Comprehensive Testing Confirms Quality of Tox21 Library’s Chemical Compounds
January 14, 2025 - NCATS News
- Assay Development and Screening Technology (ADST)
- Our Impact on Tools and Technologies
- Toxicology in the 21st Century (Tox21)
NCATS researchers assessed how well the Tox21 library’s chemicals hold up in real-world research conditions to ensure scientifically valid outcomes.
Read ArticleNIH More Than Triples Its Investments in Digital Health Technology Research
January 3, 2025 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Informatics (IFX)
- Our Impact on Tools and Technologies
A new study by NCATS researchers showed that NIH has more than tripled its funding for research on digital health technologies in the last nine years.
NCATS Researchers Help Gene Therapy for AADC Deficiency Gain FDA Approval
December 13, 2024 - NCATS News
- Therapeutics for Rare and Neglected Diseases (TRND)
NCATS’ Therapeutics for Rare and Neglected Diseases (TRND) program helped develop a recently approved gene therapy for a rare genetic brain disorder.
New Screening Tool Could Rapidly Reveal Better Cancer-Drug Combinations
December 9, 2024 - NCATS News
Scientists at NCATS and NCI designed a screening method that could help predict in the lab how combos of three or more cancer drugs will work in people.
Featured Events
FDA-NIH Rare Disease Day 2025
February 27, 2025 - February 28, 2025 - Meeting
Location: NIH Main Campus, Natcher Conference Center
Time: 10 a.m. – 4 p.m. EST
This year, NCATS and the U.S. Food and Drug Administration will sponsor a shared Rare Disease Day hybrid event as part of this global observance. FDA-NIH Rare Disease Day seeks to bring together a broad audience including patients, patient advocates, caregivers, health care providers, researchers, trainees, students, industry representatives and government staff.
Advancing Translational Science
Our Impact
Learn how our work speeds research and improves health. Key areas include big data, clinical trials and rare diseases.
Research Activities
Explore our research labs, projects and collaborations that are advancing translational science. Our largest program is the Clinical and Translational Science Awards (CTSA) Program.
Training & Education
Enhance your knowledge of translational science through programs, activities and resources offered by NCATS and our partner institutions.
Resources for You
Whether you're a researcher, an aspiring translational scientist or an interested member of the community, find information and materials important to you.
For Researchers
Learn about our latest opportunities for funding and collaboration and connect with our staff.
For Trainees
Learn about the resources and support available to help you grow as a translational scientist.
For Patients and Advocates
Learn about the patient-focused research and resources available through NCATS and NIH.
Director's Corner
Joni L. Rutter, Ph.D.
Easing the Burden of Rare Diseases Through Translational Science
November 12, 2024
NCATS Director Joni Rutter kicks off a new message series on progress and priorities in rare diseases research across the translational pipeline.
About the NCATS Director
Joni L. Rutter, Ph.D., is the director of NCATS at NIH. Rutter oversees the planning and execution of NCATS complex, multifaceted programs.
Previous Director's Messages
Search all Director's Messages by topic and year.
Subscribe to NCATS’ Community Update
Sign up to receive email messages from Dr. Rutter on center initiatives, input opportunities, events and other activities.